Portfolio company
Cell Pathways
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops medicines to treat and prevent precancerous lesions and cancer for patients in the oncology and dental markets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Apexian Pharmaceuticals
This company develops oral small molecule drugs targeting specific proteins to treat patients with cancer and inflammatory bowel diseases.
Cellemedy
The company develops next-generation protein therapeutics and immuno-oncology drugs for patients suffering from cancer.
D2G Oncology
This company develops genomic drug screening platforms and mouse models to identify genotype-specific cancer treatments for healthcare institutions and pharmaceutical researchers.
1200 Pharma
This biotechnology firm develops small molecule therapies and drug intellectual property for the treatment of cancer patients.
Calithera
This pharmaceutical company develops small-molecule drugs targeting cancer metabolism and tumour immunology for healthcare providers and patients with oncology and haematology conditions.
Pharmasset
This biopharma company develops medicines for patients suffering from HIV, viral hepatitis, cancer, and inflammatory diseases.
Depomed
This pharmaceutical company develops and markets branded prescription medicines for patients with neurology, oncology, and inflammatory conditions.